Tag: Zimmer Biomet

Zimmer Biomet

First-of-its-kind treatment for young patients with scoliosis receives FDA approval

Zimmer Biomet recently announced US Food and Drug Administration (FDA) approval for The Tether for treatment of scoliosis, providing a fusion-less alternative for young...

Zimmer Biomet recalls 1,360 spinal fusion and long bone stimulators

Zimmer Biomet recalled 1,360 spinal fusion and long bone stimulators due to a lack of adequate validation and controls to ensure product cleanliness. The...

Zimmer Biomet Spine announces FDA approval of Mobi-C cervical disc labelling...

  Zimmer Biomet has announced that the US Food and Drug Administration (FDA) has approved an extension to the Mobi-C Cervical Disc labelling to include...
Concorde

Global orthopaedic devices market worth US$47.7 billion by 2026

  The "Orthopaedic devices market size, share and trends analysis report by application (hip, knee, spine, cranio-maxillofacial, dental, SET), by product (accessories, surgical devices), and segment...
robotics

Costs curbing the rise of robotics in spinal surgery

The era of routine robotic-assisted spinal surgery is on the horizon. Despite the hype, however, there remains little market penetration, with affordability and the degree...

Zimmer Biomet announces 510(k) clearance for Zyston strut open titanium interbody...

The US Food and Drug Administration (FDA) has given 510(k) clearance for the Zyston strut open titanium interbody spacer system (Zimmer Biomet). This marks...

Scoliosis Research Society collaborates with corporate partners and International Spine Study...

The Scoliosis Research Society (SRS) has partnered with Globus Medical, K2M, Medtronic, NuVasive, Zimmer Biomet, and the International Spine Study Group Foundation (ISSGF) to...
Zimmer Biomet

Zimmer Biomet launches Avenue T TLIF cage

Zimmer Biomet has officially launched the Avenue T transforaminal lumbar interbody fusion (TLIF) cage in the USA. Avenue T incorporates VerteBridge plating. This is...
Zimmer Biomet

David Dvorak resigns as Zimmer Biomet president and chief executive officer

David C Dvorak has stepped down as Zimmer Biomet’s president, chief executive officer and member of the Board of Directors after 10 years at...

Three podium presentations demonstrate positive results for Zimmer Biomet’s Mobi-C

Results from three studies presented at the 2017 French Spine Society Congress (SFCR; June  1–3, Lille, France) have demonstrated the short and long-term safety,...
Zimmer Biomet

Zimmer Biomet recalls implantable spinal fusion stimulators

Zimmer Biomet has begun the process of recalling its SpF Plus-Mini and SpF XL IIb implantable spinal fusion stimulators in the USA, “due to...

Zimmer Biomet mandates corrective action for certain Rosa Spine models

Zimmer Biomet has issued a voluntary field action notice to users of some of its Rosa Spine, Rosa One and Rosa Brain models. Citing...

Zimmer Biomet to replace Robert Delp with Stuart Kleopfer as president...

Effective January 23, 2017, Robert Delp will assume the position of president, Americas, and join the executive leadership team of the Zimmer Biomet. He...

Zimmer Biomet launches new PrimaGen advanced allograft

Zimmer Biomet has launched the PrimaGen advanced allograft. According to a press release, this autograft substitute offers the same bone-healing elements as autograft, but...

Zimmer Biomet’s Mobi-C now most widely covered artificial cervical disc in...

Zimmer Biomet’s Mobi-C cervical disc prosthesis has become the most widely covered device for one- and two-level cervical disc replacement by commercial health insurers...

Seven-year data find Zimmer Biomet’s Mobi-C statistically superior to ACDF

Zimmer Biomet has announced results of a seven-year outcomes study demonstrating statistical superiority of its Mobi-C cervical disc prosthesis vs two-level anterior cervical discectomy...